EPISODE · Oct 31, 2024 · 27 MIN
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
from Treating Together · host Targeted Oncology
In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.
Embed this episode
Ready to play
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
No transcript for this episode yet
Similar Episodes
No similar episodes found.